Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -68.665% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Br.COC(=O)c1ccc(OCCN2C3=NCCN3c3ccccc32)cc1
b CCN(CC)C(=O)CSc1nc2[nH]ncc2c(=O)[nH]1
Answer: a. Br.COC(=O)c1ccc(OCCN2C3=NCCN3c3ccccc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Br.COC(=O)c1ccc(OCCN2C3=NCCN3c3ccccc32)cc1
Br.COC(=O)c1ccc(OCCN2C3=NCCN3c3ccccc32)cc1
methyl 4-[2-(1,2-dihydroimidazo[1,2-a]benzimidazol-4-yl)ethoxy]benzoate;hydrobromide